These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 16006449)

  • 1. Mechanisms of resistance to telithromycin in Streptococcus pneumoniae.
    Hisanaga T; Hoban DJ; Zhanel GG
    J Antimicrob Chemother; 2005 Sep; 56(3):447-50. PubMed ID: 16006449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time-kill study of the activity of telithromycin against macrolide-resistant Streptococcus pneumoniae Isolates with 23S rRNA mutations and changes in ribosomal proteins L4 and L22.
    Reinert RR; Al-Lahham A
    Antimicrob Agents Chemother; 2005 Jul; 49(7):3011-3. PubMed ID: 15980387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-level telithromycin resistance in laboratory-generated mutants of Streptococcus pneumoniae.
    Walsh F; Willcock J; Amyes S
    J Antimicrob Chemother; 2003 Sep; 52(3):345-53. PubMed ID: 12917252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The first telithromycin-resistant Streptococcus pneumoniae isolate in Japan associated with erm(B) and mutations in 23S rRNA and riboprotein L4.
    Hirakata Y; Mizuta Y; Wada A; Kondoh A; Kurihara S; Izumikawa K; Seki M; Yanagihara K; Miyazaki Y; Tomono K; Kohno S
    Jpn J Infect Dis; 2007 Feb; 60(1):48-50. PubMed ID: 17314426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activities of telithromycin, linezolid, and quinupristin-dalfopristin against Streptococcus pneumoniae with macrolide resistance due to ribosomal mutations.
    Farrell DJ; Morrissey I; Bakker S; Buckridge S; Felmingham D
    Antimicrob Agents Chemother; 2004 Aug; 48(8):3169-71. PubMed ID: 15273142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrolide-resistance mechanisms in Streptococcus pneumoniae isolates from Belgium.
    Van Eldere J; Meekers E; Lagrou K; Massonet C; Canu A; Devenyns I; Verhaegen J; Syrogiannopoulos G; Leclercq R
    Clin Microbiol Infect; 2005 Apr; 11(4):332-4. PubMed ID: 15760433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-level telithromycin resistance in a clinical isolate of Streptococcus pneumoniae.
    Wolter N; Smith AM; Low DE; Klugman KP
    Antimicrob Agents Chemother; 2007 Mar; 51(3):1092-5. PubMed ID: 17210764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylation of 23S rRNA nucleotide G748 by RlmAII methyltransferase renders Streptococcus pneumoniae telithromycin susceptible.
    Takaya A; Sato Y; Shoji T; Yamamoto T
    Antimicrob Agents Chemother; 2013 Aug; 57(8):3789-96. PubMed ID: 23716046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of telithromycin against Streptococcus pneumoniae with ribosomal mutations utilizing in vitro time-kill methodology.
    Dandekar PK; Tessier PR; Farrell DJ; Nightingale CH; Nicolau DP
    Int J Antimicrob Agents; 2005 Oct; 26(4):331-4. PubMed ID: 16144757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of erythromycin-resistant Streptococcus pneumoniae in Korea, and In Vitro activity of telithromycin against erythromycin-resistant Streptococcus pneumoniae.
    Kim NJ; Park SJ; Choi SH; Lee MS; Choo EJ; Kwak YG; Woo JH; Ryu J; Jeong JY; Kim YS
    Microb Drug Resist; 2005; 11(3):260-5. PubMed ID: 16201929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibilities to telithromycin and six other agents and prevalence of macrolide resistance due to L4 ribosomal protein mutation among 992 Pneumococci from 10 central and Eastern European countries.
    Nagai K; Appelbaum PC; Davies TA; Kelly LM; Hoellman DB; Andrasevic AT; Drukalska L; Hryniewicz W; Jacobs MR; Kolman J; Miciuleviciene J; Pana M; Setchanova L; Thege MK; Hupkova H; Trupl J; Urbaskova P
    Antimicrob Agents Chemother; 2002 Feb; 46(2):371-7. PubMed ID: 11796344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diversity of ribosomal mutations conferring resistance to macrolides, clindamycin, streptogramin, and telithromycin in Streptococcus pneumoniae.
    Canu A; Malbruny B; Coquemont M; Davies TA; Appelbaum PC; Leclercq R
    Antimicrob Agents Chemother; 2002 Jan; 46(1):125-31. PubMed ID: 11751122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time-kill kinetics of Streptococcus pneumoniae with reduced susceptibility to telithromycin.
    Al-Lahham A; Reinert RR
    Chemotherapy; 2007; 53(3):190-3. PubMed ID: 17347565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae.
    Mazzariol A; Koncan R; Vitali LA; Cornaglia G
    J Antimicrob Chemother; 2007 Jun; 59(6):1171-6. PubMed ID: 17405779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RlmCD-mediated U747 methylation promotes efficient G748 methylation by methyltransferase RlmAII in 23S rRNA in Streptococcus pneumoniae; interplay between two rRNA methylations responsible for telithromycin susceptibility.
    Shoji T; Takaya A; Sato Y; Kimura S; Suzuki T; Yamamoto T
    Nucleic Acids Res; 2015 Oct; 43(18):8964-72. PubMed ID: 26365244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular analytical evaluation of macrolide- and ketolide-resistant Streptococcus pneumoniae--mechanism of action of telithromycin and resistance to it].
    Inoue M; Kaneko K; Nakano R; Sato Y; Arai S
    Jpn J Antibiot; 2004 Oct; 57(5):425-37. PubMed ID: 15655904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ketolide resistance in Streptococcus pyogenes correlates with the degree of rRNA dimethylation by Erm.
    Douthwaite S; Jalava J; Jakobsen L
    Mol Microbiol; 2005 Oct; 58(2):613-22. PubMed ID: 16194243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrolide resistance by ribosomal mutation in clinical isolates of Streptococcus pneumoniae from the PROTEKT 1999-2000 study.
    Farrell DJ; Douthwaite S; Morrissey I; Bakker S; Poehlsgaard J; Jakobsen L; Felmingham D
    Antimicrob Agents Chemother; 2003 Jun; 47(6):1777-83. PubMed ID: 12760848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibilities of Streptococcus pyogenes and Streptococcus pneumoniae to macrolides and telithromycin: data from an Italian multicenter study.
    Mazzariol A; Koncan R; Bahar G; Cornaglia G
    J Chemother; 2007 Oct; 19(5):500-7. PubMed ID: 18073148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the efficacy of telithromycin simulating human exposures against S. pneumoniae with ribosomal mutations in a murine pneumonia model.
    Dandekar PK; Williams P; Tessier PR; Farrell DJ; Nightingale CH; Nicolau DP
    Int J Antimicrob Agents; 2005 Jun; 25(6):530-4. PubMed ID: 15894464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.